FDA Approves Linzess to Treat Constipation in Children, Teens

WEDNESDAY, June 14, 2023 -- The U.S. Food and Drug Administration approved Linzess (linaclotide) as a once-daily treatment for pediatric patients ages 6 to 17 years with functional constipation.
The approval was based on data from 328 participants...